Oramed Pharmaceuticals
ORMP
#9179
Rank
HK$1.40 B
Marketcap
HK$34.30
Share price
-0.23%
Change (1 day)
79.85%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2026 (TTM): HK$33.81

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$33.90. In 2025 the company made an earnings per share (EPS) of HK$12.01 an increase over its 2024 EPS that were of -HK$3.77.

EPS history for Oramed Pharmaceuticals from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$33.81181.56%
2025HK$12.01-418.75%
2024-HK$3.77-442.86%
2023HK$1.10-114.89%
2022-HK$7.3820.51%
2021-HK$6.1239.29%
2020-HK$4.39-31.71%
2019-HK$6.44-4.65%
2018-HK$6.758.86%
2017-HK$6.20-9.2%
2016-HK$6.8329.85%
2015-HK$5.268.06%
2014-HK$4.875.08%
2013-HK$4.633.51%
2012-HK$4.47137.5%
2011-HK$1.88-60%
2010-HK$4.71-0%
2009-HK$4.71-16.67%
2008-HK$5.65-25%
2007-HK$7.53700%
2006-HK$0.94303.56%
2005-HK$0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
HK$32.00-5.61%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$14.93-55.95%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-HK$45.83-235.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$1.18-103.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
HK$2.98-91.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel